Global Neurovascular Intervention Devices Market 2018-2024:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
53
Global Neurovascular Intervention Devices Market 2018-2024: Favorable Reimbursement Policies Presents Market Opportunities

Dublin, May 24, 2018 (GLOBE NEWSWIRE) -- The "Neurovascular Intervention Devices Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The Neurovascular Intervention devices global market is expected to grow at a high single digit CAGR to reach $4,473.2 million by 2024

The increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in aging population, technological advancement, acquisitions and favourable reimbursements are increasing the use of artificial embolization devices, stents, thromobectomy devices and support devices which include microcatheters, embolic protection system and others as an efficient way for treating the neurovascular diseases. Neurovascular Intervention devices global market is segmented on the basis of products, applications and geography. The products are segmented into artificial embolization devices, stents, thrombectomy devices and support devices. The artificial embolization devices segment accounted the largest share in 2017 and is projected to grow at mid single digit CAGR from 2017 to 2024 due to technological advancements in coils & flow diverter, development of coils for dual application i.e. for intracranial aneurysm and arteriovenous malformation.

Key Topics Covered:

1 Executive Summary 2 Introduction 2.1 Key Takeaways 2.2 Report Scope 2.3 Report Description 2.4 Markets Covered 2.5 Stakeholders 2.6 Research Methodology 3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers And Opportunities 3.3.1.1 Increase In Incidence And Prevalence Of Neurovascular Diseases 3.3.1.2 Increase In Ageing Population 3.3.1.3 Technological Advancements In Minimally Invasive Products 3.3.1.4 Favorable Reimbursement Policies 3.3.1.5 Acquisitions 3.3.2 Restraints And Threats 3.3.2.1 Adverse Events And Complications With The Implantations Of Neurovascular Intervention Devices 3.3.2.2 Lack Of Skilled And Trained Professionals 3.3.2.3 Product Recalls 3.3.2.4 Stringent Regulatory Polices 3.3.2.5 Availability Of Alternative Products 3.4 Regulatory Affairs 3.5 Reimbursement Scenario 3.6 Clinical Trials 3.7 Patent Trends 3.8 Technological Advancements 3.8.1 Introduction 3.8.2 Integrated Balloon System 3.8.3 Soft Coil Technology 3.8.4 Adujstable Clot Retreiver 3.8.5 Advancements In Flow Diverter 3.9 Product Approvals 3.10 Porter's Five Force Analysis 3.11 Supply Chain Analysis 3.12 Market Share Analysis By Major Players 3.13 Neurovascular Intervention Devices Number Of Units By Region 3.14 Neurovascular Intervention Devices Company Comparison Table By Classification, Products And Applications 3.15 Market Penetration Of Neurovascular Intervention Device Market 4 Neurovascular Intervention Devices Global Market, By Product 4.1 Introduction 4.2 Artificial Embolization Devices 4.2.1 Coils 4.2.1.1 Bare Metal Coils 4.2.1.2 Coated Coils 4.2.2 Liquid Embolics 4.2.3 Flow Diverters 4.2.4 Flow Disruptor 4.3 Stents 4.3.1 Intracranial Stents 4.3.1.1 Stenosis Stents 4.3.1.2 Aneurysm Coil Stents 4.3.1.3 Neck Reconstruction Stents 4.3.1.4 Stent Graft 4.3.2 Carotid Stents 4.4 Thrombectomy Devices 4.4.1 Stent Retrievers 4.4.2 Aspiration Devices 4.5 Support Devices 4.5.1 Microcatheters 4.5.2 Embolic Protection System 4.5.3 Others 5 Neurovascular Intervention Devices Global Market, By Application 5.1 Introduction 5.2 Intracranial Aneurysm 5.3 Ischemic Stroke 5.4 Arteriovenous Malformation 5.5 Carotid Stenosis And Others 6 Regional Analysis 7 Competitive Landscape 7.1 Introduction 7.2 Agreement 7.3 Approvals 7.4 Acquisitions 7.5 New Product Launch 7.6 Other Developments 8 Major Companies

  • Asahi Intecc Co., Ltd.
  • Balt Extrusion
  • Balton Sp. z o.o.
  • Boston Scientific Corporation
  • Cardiatis
  • Cardinal Health Inc
  • Contego Medical, LLC
  • Evasc Medical Systems
  • Inspire MD
  • Johnson & Johnson
  • Medtronic Plc
  • Merlin MD Pte. Ltd.
  • Microport Scientific Corporation
  • NexGen Medical Systems, Inc
  • Oxford Endovascular Ltd
  • Penumbra Inc
  • Perflow Medical Ltd
  • Phenox GmbH
  • Rapid Medical
  • Silk Road Medical Inc
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc

For more information about this report visit https://www.researchandmarkets.com/research/6...lobal?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Neurology Devices

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

IQVentures Acquires Aaron's Company for $504 Million Deal

Updated Category News Views 131

IQVentures Acquires Aaron's Company The acquisition landscape recently shifted with IQVentures Holdings, LLC, completing its purchase of Aaron's Company, Inc. (NYSE: AAN) in a landmark deal valued at approximately $504 million. This significant move culminates in a price of $10.10 per share, leading to the cessation of trading for Aaron's common stock on major exchanges....

Continue Reading
Vistra Increases Dividend for Common and Preferred Stockholders

Updated Category News Views 145

Vistra Boosts Shareholder Returns with Increased Dividends Vistra, a prominent player in the power generation and retail electricity sectors, has made headlines with its recent announcement regarding dividends. The company's board of directors has declared a quarterly dividend of $0.2260 per share for common stock holdings, amounting to a substantial total payout of...

Continue Reading
Hyperscale Data's Bitcoin Treasury Strategy Revealed

Updated Category News Views 126

Hyperscale Data's Bitcoin Treasury Update Hyperscale Data, Inc. (NYSE American: GPUS), known for its innovative approaches to artificial intelligence and digital asset management, has reached a notable milestone. The company recently reported holding approximately 545.4218 Bitcoin, which is a significant increase compared to their previous estimates. This treasury is part...

Continue Reading
Clarivate's Third Quarter Financial Performance and Future Outlook

Updated Category News Views 154

Overview of Clarivate's Q3 Financial Results Clarivate Plc (NYSE: CLVT), a noted global provider of transformative intelligence, has shared its financial results for the third quarter of the fiscal year. The company has seen continued acceleration in organic annual contract value (ACV) during this period. Significant Financial Highlights In this quarter, Clarivate's total...

Continue Reading
NexGold Advances with Industrial Approval for Goldboro Project

Updated Category News Views 180

NexGold Celebrates a Key Milestone in Project Development NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF), a dedicated gold-focused mining company, has recently reached an important milestone by securing Industrial Approval (IA) for the Goldboro Gold Project. This approval comes from the Government of Nova Scotia and represents one of the final provincial permits needed...

Continue Reading